Oclacitinib is a Janus kinase (JAK) inhibitor that targets chemical signals (cytokines) involved in itch and inflammation in allergic skin disease. By blocking these signals, itch intensity and skin irritation are reduced.
ilunocitinib is a Janus kinase (JAK) inhibitor that interrupts inflammatory and itch signalling pathways involved in allergic reactions in the skin. It is a newer alternative to Oclacitinib (Apoquel) that is slightly more targeted to itch pathways.
Lokivetmab is a monoclonal antibody that specifically neutralises interleukin-31 (IL-31), a key cytokine that drives the itch response in dogs with allergic skin disease.
Ciclosporin is an immunomodulator that dampens immune responses that drive allergic inflammation, helping reduce itching and skin changes over time.
If you have any questions or concerns, please don't hesitate to reach out to us. You can contact us via phone, email, or social media. We are always happy to hear from our visitors!
If you have any questions or concerns, please don't hesitate to reach out to us. You can contact us via phone, email, or social media. We are always happy to hear from our visitors!
Are not licensed for canine allergic dermatitis and generally have limited benefit; they may help mild itch in some dogs but are not reliable as sole therapy